JAIME ZIPSIR: Open Payments
NPI 1164476164 · ANCHORAGE, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,045 in 31 payments from 9 companies in 2025. Trend: 2023 $838 · 2024 $905 · 2025 $1,045
Food & beverage: $1,045
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 8 | $344 |
| PFIZER INC. | 10 | $235 |
| Astellas Pharma US Inc | 4 | $106 |
| 180 Medical, Inc. | 1 | $97 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $86 |
| ACCORD HEALTHCARE, INC. | 1 | $84 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| Janssen Biotech, Inc. | 2 | $32 |
| Olympus America Inc. | 1 | $22 |
Products named: GEMTESA, Xtandi, GENTLECATH, Camcevi, PLUVICTO, Bard Urinary Drainage Bag, ERLEADA, iTIND System.
Industry payments across AK — which companies pay providers there.
